Scaling dynamic response and destructive metabolism in an immunosurveillant anti-tumor system modulated by different external periodic interventions.
On the basis of two universal power-law scaling laws, i.e. the scaling dynamic hysteresis in physics and the allometric scaling metabolism in biosystem, we studied the dynamic response and the evolution of an immunosurveillant anti-tumor system subjected to a periodic external intervention, which is equivalent to the scheme of a radiotherapy or chemotherapy, within the framework of the growth dynamics of tumor. Under the modulation of either an abrupt or a gradual change external intervention, the population density of tumors exhibits a dynamic hysteresis to the intervention. The area of dynamic hysteresis loop characterizes a sort of dissipative-therapeutic relationship of the dynamic responding of treated tumors with the dose consumption of accumulated external intervention per cycle of therapy. Scaling the area of dynamic hysteresis loops against the intensity of an external intervention, we deduced a characteristic quantity which was defined as the theoretical therapeutic effectiveness of treated tumor and related with the destructive metabolism of tumor under treatment. The calculated dose-effectiveness profiles, namely the dose cumulant per cycle of intervention versus the therapeutic effectiveness, could be well scaled into a universal quadratic formula regardless of either an abrupt or a gradual change intervention involved. We present a new concept, i.e., the therapy-effect matrix and the dose cumulant matrix, to expound the new finding observed in the growth and regression dynamics of a modulated anti-tumor system.
School of Physics and Engineering, Department of Physics, Sun Yat-sen University, Guangzhou, China. stssyz@mail.sysu.edu.cn
Yuanzhi
Y
Shao
Wenyong
W
Hu
Weirong
W
Zhong
Li
L
Li
D000970:Antineoplastic Agents; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D008660:Metabolism; D008962:Models, Theoretical; D015166:Monitoring, Immunologic / Q000379:methods*; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000628:therapy*; D011878:Radiotherapy; D049490:Systems Biology / Q000379:methods*; D047368:Tumor Burden
D000970:Antineoplastic Agents
Phys Rev E Stat Nonlin Soft Matter Phys. 2001 Mar;63(3 Pt 2):036109
11308711
Phys Rev Lett. 1993 Apr 12;70(15):2336-2339
10053535
Nature. 2006 Jan 26;439(7075):457-61
16437113
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1639-43
16432236
Biol Rev Camb Philos Soc. 2010 Feb;85(1):111-38
19895606
Biol Lett. 2007 Feb 22;3(1):99-102
17443976
Phys Rev Lett. 2004 Jun 25;92(25 Pt 1):255502
15245023
J Exp Biol. 2005 May;208(Pt 9):1749-69
15855405
Phys Rev Lett. 2001 Jul 16;87(3):038101
11461594
Science. 1997 Apr 4;276(5309):122-6
9082983
PLoS Comput Biol. 2008 Sep 12;4(9):e1000171
18787686
J Biol Chem. 1997 Feb 21;272(8):4680-8
9030519
Am Nat. 2009 Nov;174(5):720-33
19799501
Phys Rev E Stat Nonlin Soft Matter Phys. 2001 Jan;63(1 Pt 2):016120
11304327
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15502-5
17023538
Nature. 2010 Apr 1;464(7289):753-6
20360740
Comp Biochem Physiol A Mol Integr Physiol. 2008 Sep;151(1):5-28
18617429
Nature. 2003 Jun 5;423(6940):639-42
12789338
Science. 2002 Mar 22;295(5563):2229-30
11910100
Phys Rev E Stat Nonlin Soft Matter Phys. 2004 Jun;69(6 Pt 1):061106
15244539
Nat Rev Cancer. 2005 Jul;5(7):516-25
15965493
Evolution. 2009 Oct;63(10):2658-67
19519636